Medicine information
Uses & overview
VOGLIGOLD G3 M0.3 is an oral antidiabetic combination tablet marketed by Steris Healthcare. It contains Glimepiride 3 mg, Voglibose 0.3 mg, and Metformin Hydrochloride 500 mg. These three active ingredients work through different mechanisms to support blood glucose management in adults with type 2 diabetes mellitus. Glimepiride 3 mg belongs to the sulfonylurea class of antidiabetic medicines. It helps lower blood glucose by stimulating insulin release from the pancreas. Voglibose 0.3 mg belongs to the alpha-glucosidase inhibitor class. It slows the digestion and absorption of carbohydrates in the intestine, helping reduce the rise in blood glucose levels after meals. Metformin Hydrochloride 500 mg belongs to the biguanide class. It helps reduce glucose production in the liver and improves the body's response to insulin. The combination of these ingredients may be prescribed when a healthcare professional determines that all three medicines are suitable for an individual's diabetes management plan. Treatment should be supported by a balanced diet, regular physical activity, and routine blood glucose monitoring. VOGLIGOLD G3 M0.3 should be used only under medical supervision. Its suitability depends on the patient's blood glucose levels, medical history, kidney and liver function, current medicines, and response to treatment.
How to use
Take VOGLIGOLD G3 M0.3 exactly as prescribed by your doctor. Follow the dosage and meal-related instructions provided by your healthcare professional and the approved product information. Voglibose-containing medicines are generally taken immediately before meals, while metformin is commonly taken with meals to improve gastrointestinal tolerability. Follow the specific administration instructions for this combination tablet. Swallow the tablet with water as directed. Do not change the prescribed dose or discontinue treatment without consulting your doctor. Maintain regular meal timings, follow your recommended diet and exercise plan, and monitor blood glucose levels as advised. Glimepiride can cause low blood sugar, particularly when meals are skipped or delayed. If you experience sweating, shaking, dizziness, unusual hunger, or confusion, follow your doctor's recommended hypoglycaemia management plan.
Storage
Store VOGLIGOLD G3 M0.3 according to the instructions printed on the product packaging. Keep the tablets in their original packaging and protect them from excessive heat, moisture, and direct sunlight. Keep the medicine out of the reach of children. Do not use tablets after their expiry date. Dispose of unused or expired medicine responsibly according to local pharmaceutical disposal guidance.
